Patient Choices Between Home and In-Center Dialysis in Kidney Failure

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with advanced chronic kidney disease who are getting information about treatment methods before starting. They fill in a questionnaire about their dialysis preferences.

Age

Adults, 18 years or older

Sex

All

Disease stage

Advanced chronic kidney disease, at the stage of receiving information about treatment methods

Earlier treatment

People who are switching from one kidney replacement method to another cannot join.

Main reasons for not taking part

• Under 18 years old
• Switching from one method of kidney replacement to another
• Needing urgent dialysis
• Cannot read or understand French
• Under legal protection (guardianship, curatorship, judicial protection)

The registry criteria, word for word

What the trial wants to find out

Background Compared to in-center dialysis, home dialysis is associated with better quality of life and lower healthcare system costs. However, barriers remain to its wider adoption. Chronic disease, particularly at an advanced stage, is a major driver of socioeconomic vulnerability. Among dialysis patients, the proportion of individuals covered by France's Universal Health Protection scheme (PUMA) is higher than in the general population. Similarly, those from the most disadvantaged social classes are overrepresented among dialysis patients compared to the overall French population. Dialysis can also lead to job loss. Financial compensation schemes may influence the choice of home dialysis. In France, patients who perform dialysis at home-either independently or with help from a trained family caregiver-are eligible for a "third-person compensatory allowance" (DTP). For some socioeconomically vulnerable patients, eligibility for DTP may influence their decision to opt for home treatment. The DTP is specific to the French healthcare system but could be considered in other countries, particularly within the European Union. Indeed, in most countries with income levels comparable to France, the additional cost of home dialysis is borne by the patient. This study aims to determine whether receiving financial compensation plays a role in choosing a dialysis modality (home-based versus in-center or assisted home dialysis).

The group in the trial

• Choice of dialysis

  Patients with an end-stage renal disease who need to make a choice concerning their prefered dialysis' modality

  Treatment: Questionnaire